A AB BS S T TR RA AC CT T O Ob bj je ec ct ti iv ve e: : Alt ho ugh um bi li cal cord blo od (UCB) is a use ful so ur ce of stem and pro geni tor cells for bo ne mar row trans plan ta ti on, it is not pos sib le to ob ta in suf fi ci ent num ber of trans plantab le cells from a sing le hu man um bi li cal cord for trans plan ta ti on in adult pa ti ents. In this study, we com bi ned early and la te growth fac tors in short term cul tu res to en rich cord blo od CD34+ he ma topo i e tic pro ge ni tor cell co unt for adult pa ti ents. M Ma a t te e r ri i a al l a an nd d M Me et t h ho od ds s: : Cord blo od mo no nuc le ar cells (CBMC) har ves ted from 15 he althy vo lun te ers, de li ve ring in term, in cu ba ted in cul tu re me di um supp le men ted with in ter le u kin-3 (IL-3), IL-6, IL-11, stem cell fac tor, flt3/flk2 li gand and throm bo po i etin for 14 days. Star ting cells and cul tu red cells (day 7 and 14 cells) we re eva lu a ted for; CD4, CD8, CD33, CD34, CD38 and HLA-DR by flow cyto metry and se e ded in se mi so lid methy lcel lu lo se cul ture for de ter mi ning BFU-E, CFU-GM and CFU-GEMM co lony for ming abi li ti es. R Re e s su ul lt ts s: : In the shortterm cul tu res, to tal CBMC co unt sig ni fi cantly in cre a sed (p= 0.0001). Com pa red to star ting cells, the ex pres si ons of CD34 (p= 0.002), CD33 (p= 0.0001), HLA-DR (p= 0.0001) and CD8 (p= 0.002) in cre ased, but tho se of CD38 (p= 0.057) and CD4 (p= 0.0001) we re sup pres sed on day 14 of cul tu res. The re we re an in cre a se in ge ne ra ti on of CFU-GM (p= 0.131) and CFU-GEMM (p= 0.134) co lo ni es and a signi fi cant dec re a se in ge ne ra ti on of BFU-E co lo ni es (p= 0.0001). C Co on nc c l lu u s si i o on n: : Ex vi vo ex pan si on of CBMC, un der com bi na ti on of the growth fac tors, con tri bu te to CD34+ pro ge ni tor cell co unt and may help to re ach suf fi ci ent amo unt of trans plan tab le cells for adult pa ti ents. Sus pen si on cul tu res may lead to eli mi na ti on of graft-ver sus-host di se a se risk and pro tec ti on of graft-ver sus-le u ke mi a ef fect, through the dec re a se of CD4+ T cells and ma in te nan ce of CD8+ T lymphocy tes, res pec ti vely.
m bi li cal cord blo od (UCB) is an al ter na ti ve to bo ne mar row or mo bi li zed pe rip he ral blo od for trans plan ta ti on sin ce it is re a dily ava i lab le and is en ric hed in pri mi ti ve he ma to po i etic cells. [1] [2] [3] Cli ni cal re sults with cord blo od stem cell trans plan ta ti on show a high pro ba bi lity of en graftment and a low risk of acu te graft-ver sus-host di sea se (GvHD). Ot her ad van ta ges of UCB use are the ab sen ce of risks for the do nor and a low risk of infec ti o us di se a se trans mis si on. [4] [5] [6] Alt ho ugh a num ber of suc cess ful uses of UCB in he ma to po i e tic ma lig nan ci es, the ma jor go al is to achi e ve to en rich UCB stem cells to suf fi ci ent num bers for trans plan ting to adult pa ti ents. 7 So me UCB samp les may con ta in suf fi ci ent amo unts of he ma to po i etic stem cells (HSC) for trans plan ting pe di at ric pa ti ents but ge ne rally the num ber of HSC is not adequ a te in one UCB samp le. 8, 9 The ma jor li mi ta ti ons of using UCB as a so urce of stem / pro ge ni tor cells for cli ni cal trans planta ti on is the li mi ted vo lu me pro vi ding in suf fi ci ent num ber of HSC to re cons ti tu te he mo po i e sis in older chil dren and adults. 10 To over co me this li mi tati on, ex vi vo ex pan si on of pri mi ti ve cells has be en at temp ted. 11, 12 Ex vi vo ex pan si on of hu man HSC is an impor tant is su e in trans plan ta ti on and ge ne the rapy. 13 Se ve ral stem cell ex pan si on pro to cols ha ve be en pro po sed. Thus, se ve ral com bi na ti ons of cyto ki nes known to act on pri mi ti ve HSC ha ve emp lo yed in vit ro in an at tempt to pro du ce cul tu re con di ti ons su i tab le for HSC ex pan si on. The li gand for c-kit (stem cell fac tor; SCF) and flt3/flk2 li gand (FL), in ter le u kin-3 (IL-3), IL-6 throm bo po i e tin (Tpo) are cru ci al to sti mu la te pri mi ti ve HSC expan si on. [14] [15] [16] [17] Ex pe ri men tal and cli ni cal he ma to lo gi cal stu di es pro vi de us iden ti fi ca ti on of mec ha nisms and con di ti ons that sup port the ex pan si on of trans plantab le HSC in vit ro. 18, 19 Ex vi vo cul tu res al low a more ra ti o nal ap pro ach for the de ve lop ment of cli ni cal tre at ments in vol ving pri mi ti ve HSC. [20] [21] [22] [23] Iden ti fi ca ti on of con di ti ons that sup port the self-re ne wal and ex pan si on of hu man HSC has stimu la ted con si de rab le in te rest in the bi o logy of cord blo od cell s' ex vi vo ex pan si on in va ri o us in vit ro cul tu re systems. 24, 25 To en han ce the ra pi dity of en graft ment and iso la ti on and ac ti va ti on of se lec ted im mu ne cell popu la ti ons for pre ven ti on or tre at ment of acu te GvHD, in fec ti o us comp li ca ti ons and tu mor re-occur ren ce, se ve ral are as of on go ing re se arch inc lu de ex vi vo ex pan si on of cord blo od he ma to po i e tic proge ni tor cells. 26 In this study, we used first ti me a wi de ar ray of a growth fac tor com bi na ti on such as IL-3, IL-6, IL-11, SCF, FL and Tpo and ai med to de ter mi ne the effects of the early and la te growth fac tors on CD34 + he ma to po i e tic pro ge ni tor cells, co lony for ming abi lity of the cells in short term sus pen si on cul tu re.
MA TE RI AL AND MET HODS

CORD BLO OD SAMP LES
UCB samp les we re col lec ted by gra vity from the um bi li cal ve in af ter the comp le ti on of de li very in to ste ri le 20 ml tu bes, con ta i ning 750 IU of pre ser va tive-fre e he pa rin (Sig ma Che mi cal Co., St. Lo u is, MO, USA). All de li ve ri es we re nor mal and full term. Infor med con sents we re ob ta i ned from all ca ses and the samp les we re pro ces sed wit hin 4 h of col lec ti on. The pro ce du re had the Is tan bul Uni ver sity, Is tan bul Me di cal Fa culty Et hics Com mit te e ap pro val.
COL LEC TI ON AND ISO LA TI ON OF MO NO NUC LE AR CELLS
The cord blo od mo no nuc le ar cells (CBMC) we re se pa ra ted by His to pa qu e-1077 (Sig ma Che mi cal Co., St. Lo u is, MO, USA; d= 1077 g/ml) den sity cen tri fu ga ti on. Af ter was hing twi ce, cell vi a bi lity was me a su red by trypan blu e (Sig ma Che mi cal Co., St. Lo u is, MO, USA) dye exc lu si on 27 and it was more than 96% in all samp les. An ali qu ot of cells was used for the de ter mi na ti on of the com mit ted hemo po i e tic pro ge ni tors and CD4, CD8, CD33, CD34, CD38, HLA-DR ex pres si ons.
LI QU ID SUS PEN SI ON CUL TU RES
CBMC we re in cu ba ted in Is co ve's Mo di fi ed Dulbec co's Me di um (IMDM, Sig ma Che mi cal Co., St. Lo u is, MO, USA) supp le men ted with 10% fo e tal calf se rum (FCS, Sig ma Che mi cal Co., St. Lo u is, MO, USA) in the pre sen ce of 20 ng/mL IL-3, 20
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Tıbbi Biyoloji ng/mL IL-6, 20 ng/mL IL-11, 20 ng/mL SCF, 20 ng/mL FL, 20 ng/mL Tpo (all from Pep ro Tech EC, Ltd. NJ. USA). A to tal of 1 × 10 6 /ml cells we re cultu red in T 25 flasks (5 mL) for 14 days at 37 o C under 5% CO 2 hu mi di fi ed air. Half of the cul tu re me di a we re re mo ved at day 7, whi le the cor respon ding ot her half we re fed with fresh me di a and growth fac tors. The cells iso la ted from the me di a we re re sus pen ded in IMDM supp le men ted with %10 FCS. Su i tab le ali qu ots of the cell sus pen si on we re chec ked for vi a bi lity by the trypan blu e exclu si on test, co un ted, im mu nop he noty ped and as sayed for co lony for ming cells.
CELL PHE NOTY PING
The an ti ge nic phe noty pe of UCB cells was as ses sed be fo re and du ring ex vi vo ex pan si on by flow cytometry. Star ting cells and cul tu red cells (day 7 and day 14 cells) at a con cen tra ti on of 0.5 x 10 6 per test tu be we re in cu ba ted with the fol lo wing mo noc lonal an ti bo di es (mAb): CD4-flu o res ce in isot hi oc yana te (FITC), CD8-phyco eryt hrin (PE), CD33-PE CD34-FITC, CD38-FITC, HLA-DR-PE (Cal tag Lab. Bur lin ga me, CA). Ap prop ri a te isoty pe con trols were used to de ter mi ne tru e per cen ta ge of po si ti ve cells (Cal tag Lab. Bur lin ga me, CA). Flow cyto metry was per for med with FACS Ca li bur (Bec ton-Dic kinson Im mu nocy to metry System) using a to tal cell ga te that eli mi na ted cel lu lar deb ris. At le ast 10.000 events we re analy zed in each samp le.
CLO NO GE NIC AS SAYS FOR COM MIT TED HE MO PO I E TIC PRO GE NI TORS
CBMC from star ting cells we re ex pan ded in li qu id cul tu res and tes ted for the growth of com mit ted hemo po i e tic pro ge ni tors using methyl cel lu lo se me dia. Methyl cel lu lo se (4.000-cen ti pi o se, Sig ma Che mi cal Co., St. Lo u is, MO, USA) was dis sol ved in IMDM at a con cen tra ti on of 3 g per 100 ml. The me di a supp le men ted with 30% FCS, 1% bo vi ne serum al bu min (BSA, Sig ma Che mi cal Co., St. Lo u is, MO, USA), 200 mmol/L L-glu ta mi ne (Sig ma Chemi cal Co., St. Lo u is, MO, USA), 10 -5 mol/L so di um se le ni te (Sig ma Che mi cal Co., St. Lo u is, MO, USA), 10 -1 mol/L α-mo no ti yog li se rol (Sig ma Che mi cal Co., St. Lo u is, MO, USA), 100 µL of su per na tant from 10 ng/mL phyto he magg lu ti nin (PHA, Bi oc hrom KG, Ber lin, Ger many) sti mu la ted pe rip he ral blo od mono nuc le ar cells 28 at a fi nal vo lu me of 1.1 ml in 35 mm pet ri dis hes. Co lony growth was sti mu la ted with 3 IU/ml erit ro po i e tin (EPO; Ep rex, Ci lag AG, Zug, Swit zer land), 50 ng/ml gra nu locy te mac ropha ge-co lony sti mu la ting fac tor (GM-CSF; Le u comax, San doz, No var tis Far ma AG, Ba sel, Swe den) and 10 ng/ml gra nu locy te-co lony sti mu la ting factor (G-CSF; Ne u po gen, Am gen, F. Hoff mann-LA Roc he Ltd. Ba sel, Swe den). Cul tu res we re pla ted in trip li ca te, in cu ba ted at 37 o C in a 5% CO 2 fully humi di fi ed at mosp he re for 14 days. Co lo ni es we re iden ti fi ed and sco red un der an in ver ted mic ros co pe ac cor ding to stan dard cri te ri a. 29 Burst for ming units erit hro id (BFU E) co lo ni es sco red as com pact co lo nies that he mog lo bin con ta i ning mo re than 40 cells, Co lony-for ming units gra nu locy te/mac rop ha ge (CFU-GM) co lo ni es sco red as non-he mog lo bin conta i ning are as with mo re than 50 cells that scat ter from a den se cen tral and Co lony-for ming units granu locy te/eryt hrocy te/mac rop ha ge/me ga kar yocy te (CFU-GEMM) co lo ni es we re sco red as he mog lo bini zed are as with at le ast two mye lo id cell se ri es conta i ning co lo ni es (Fi gu re 1).
STA TIS TI CAL ANALY SIS
All re sults are ex pres sed as me an ± stan dard er ror of the me an (SE). Sta tis ti cal sig ni fi can ce was de ter mined using ANO VA with Bon fer ro ni test as post-hoc cal cu la ti on. A P-va lu e of less than 0.05 was con side red sta tis ti cally sig ni fi cant.
RE SULTS
PRO LI FE RA TI VE EF FECTS THE CYTO KI NE COCK TA IL ON TO TAL CBMC AND CD34
+ CELLS
To study the pro li fe ra ti ve ef fects of the growth factors in to tal CBMC and CD34 + cells, 15 UCB samples from he althy nor mal full-term de li ve ri es we re stu di ed. In an ef fort to in du ce the short-term proli fe ra ti on and amp li fi ca ti on of CD34 + he ma to po i etic pro ge ni tor cells, early and la te growth fac tors known to be ef fec ti ve on he ma to po i e tic pro ge nitors we re ad ded to the li qu id sus pen si on cul tu res. The re sults are shown in Tab le 1. To tal CBMC (p= 0.0001) and CD34 + cells (p= 0.002) we re sig ni ficantly in cre a sed in sus pen si on cul tu res.
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EX PRES SI ON OF MYE LO ID AND LYMPHO ID PRO GE NI TOR CELL S' SUR FA CE MO LE CU LES
To de ter mi ne the ef fects of the early and la te growth fac tors on pro ge ni tor cells, CBMC samp les we re incu ba ted in the pre sen ce of IL-3, IL-6, IL-11, SCF, FL and Tpo. Cell sur fa ce mar kers we re de tec ted by flow cyto metry. Re sults are shown Tab le 2. CD34 (p= 0.019) ex pres si on as sig ni fi cantly in cre a sed at suspen si on cul tu re pe ri od. In ad di ti on to an in cre a se in CD34 ex pres si on, CD33 (p= 0.0001) and HLA-DR (p= 0.0001) ex pres si ons we re sig ni fi cantly in cre a sed whi le CD38 (p= 0.057) ex pres si on as dec re a sed af ter 14 day sus pen si on cul tu res.
EX PRES SI ON OF T CELL AS SO CI A TED CELL SUR FA CE MO LE CU LES
Ma tu re T cell sur fa ce mar kers we re de tec ted by flow cyto metry on CBMC from fresh UCB samples, day 7 and day 14 of li qu id sus pen si on cul tu res. The re sults are shown Tab le 2. Despite a sig ni fi cant dec re a se in CD4 (p= 0.0001) ex pres si on, CD8 (p= 0.002) ex pres si on as in cre a sed in sus pen si on cul tures ini ti a ted by early ant la te growth fac tors.
AS SESS MENT OF CO LONY FOR MING CELLS IN CBMC BE FO RE AND AF TER LI QU ID SUS PEN SI ON CUL TU RES
In an at tempt to in ves ti ga te the ef fects of the early and la te growth fac tors on co lony ge ne ra ti on ca pabi lity, CBMC from fresh UCB samp les, day 7 and day 14 of li qu id sus pen si on cul tu res we re analy zed for in vit ro co lony for ma ti on (BFU-E, CFU-GM and CFU-GEMM). The re sults are shown in Tab le 3. Des pi te sig ni fi cant dec re a se in BFU-E (p= 0.0001) co lo ni es, hig her num ber of CFU-GM (p= 0.131) and CFU-GEMM (p= 0.134) co lo ni es we re de tec ted CBMC af ter days 7 and 14 of li qu id suspen si on cul tu res (Fi gu re 1).
DIS CUS SI ON
Pri mi ti ve he ma to po i e tic stem cell has self-re ne wal ca pa bi lity and dif fe ren ti a ti on in to all cell li ne a ges. This cell gro up is res pon sib le for long-term en graft- A) BFU-E co lo ni es sco red as com pact co lo ni es that he mog lo bin con ta i ning mo re than 40 cells. (Mag. ×200). B) CFU-GM co lo ni es sco red as non-he mog lo bin con ta i ning are as with more than 50 cells that scat ter from a den se core. (Mag. ×200). C) CFU-GEMM co lo ni es we re sco red as he mog lo bi ni zed are as with at le ast two mye lo id cell se ri es con ta i ning co lo ni es.
(Mag. ×100).
Cell counts
Starting cells day 7 of suspension culture day 14 of suspension culture Significance
Total CBMC 1 x10 6 ± 0.0 x10 Results are expressed as mean ± SE.
Süzergöz ve ark. Tıbbi Biyoloji ment to bo ne mar row and do es not ha ve CD34 surfa ce mo le cu les. [30] [31] [32] Na ka uc hi 33 and Osa wa et al 34 sho wed that CD34 + cells ha ve com mit ted pro ge ni tor cell pro per ti es mo re than pri mi ti ve stem cells, and Col lins 35 imp li ed that CD34 + cells we re res pon sib le for short-term bo ne mar row re-po pu la ti on. In this study, we ob ser ved that inf lu en ce of the cur rent cyto ki nes on CBMC ca u sed sig ni fi cant in cre a ses in CD34 + cells and the se cells in graft has a cru ci al impor tan ce for short-term bo ne mar row re po pu la tion. Mo re o ver, Ru bins te in et al 36 imply that CD34 + co unt is al so a go od in di ca tor for en graft ment. In our study, the in cre a se of CD34 + cells by the suspen si on cul tu re may con tri bu te en graft ment ca pabi lity of the UCB samp les as a graft in bo ne mar row trans plan ta ti on (BMT).
FL is known as a pos sib le mo du la tor of early hema to po i e tic cell growth. 37 Do o ley et al. 15 sho wed that FL sti mu la tes the ex pan si on of to tal cells, CD34 + cells, CD34 + CD33, CD34 + CD38 and CD34 + HLA-DR. In this study, in ad di ti on to sig ni fi cant in cre a ses of CD34 cell po pu la ti ons, the re we re sig ni fi cant in crea ses of CD33 and HLA-DR ex pres si ons. The re sults sho wed that the re was an in cre a se in eit her lymphoid or mye lo id pro ge ni tors of cul tu red CBMC.
Su i et al 38 ob ser ved gre a test synergy bet we en IL-6 and SCF, ac ting thro ugh the re cep tors gp130 and c-Kit res pec ti vely. SCF and IL-3, FL and Tpo, and IL-3, IL-6 and Epo we re com bi ned in short term cul tu res by Mo o re and Hoskins, 39 Pi a ci bel lo et al 40 and Mad ka i kar et al 41 res pec ti vely. In the se cul tu res ini ti a ted by the men ti o ned cyto ki nes, signi fi cant in cre a ses in to tal nuc le a ted cell co unts were re por ted. In this study, we com bi ned the se growth fac tors with IL-11 and ob ser ved an in cre ase at to tal nuc le a ted cell, but not as much as re ported in the se stu di es. In our opi ni on, this dif fe ren ce de pends on the start con di ti on of cul tu res. Li ke wise, they star ted the cul tu res with pu ri fi ed CD34 + cells, but we ini ti a ted using to tal CBMC wit ho ut any cell pu ri fi ca ti on.
We ob ser ved in cre ment in CFU-GM and GFU-GEMM co lo ni es at se mi so lid cul tu re by the cells Medical Biology Süzergöz et al from sus pen si on cul tu re ini ti a ted by the cur rent growth fac tors. The in cre a se of CFU-GM and GFU-GEMM in di ca te that UCB samp les im pro ve the gene ra ti on of pla te let and whi te blo od cell ca pa city. It is well known that ne ut rop hil and pla te let re co very are con si de red most im por tant cri te ri a for suc cess of BMT. 42 Whi le ne ut rop hils ori gi na te from CFU-GM and CFU-GEMM co lo ni es, pla te lets ta ke ori gi ne from the lat ter ones. 43, 44 We be li e ve the in cre a se of CFU-GM and CFU-GEMM co lony ge ne ra ti on abi lity by the sus pen si on cul tu res may con tri bu te plate let and ne ut rop hil re co very af ter trans plan ta ti on.
A sig ni fi cant reduction was ob ser ved in CD4 cell co unts of CBMC in the sus pen si on cul tu re peri ods. The cells, ha ving ma jor ro le ari sing GvHD in al lo ge nic trans plan ta ti ons, 45, 46 we re re mo ved from the trans plan ta ti on ma te ri al during the sus pen si on cul tu re. This re mo val of the CD4 + T cells pro vi des a lo wer risk of his to in com pa ti bi lity prob lems in trans plan ta ti ons such as GvHD in al lot rans plan tati ons.
Har ris 47 sho wed that CD8 + cyto to xic T lymphocy tes ha ve a pro tec ti ve ef fect known as graftver sus-le u ke mi a ef fects. The se cells pre vent the pati ents from re lap ses by kil ling re si du al le u ke mi a cells af ter trans plan ta ti ons. 48 In this study, CD8 + T cell we re in cre a sed af ter the sus pen si on cul tu re peri od. The per sis ten ce of CD8 cyto to xic T lymphocy tes in UCB grafts through the cul tu re pe ri od may con tri bu te to pre vent relapses in BMT pa ti ents after trans plan ta ti on by the graft-ver sus-le u ke mi a effects pro vi ded by the se cells.
As a re sult, he mo to po i e tic stem cell con tent of UCB samp les was en ric hed in sus pen si on cul tu res ini ti a ted by early and la te growth fac tors. Re mo val of the CD4 + T cells in cul tu re pe ri od may help elimi na ti on of the GvHD risk and graft-ver sus-le u kemi a ef fect might be pre ven ted by ma in te nan ce of CD8 + T lymphocy tes in UCB samp les af ter the suspen si on cul tu res.
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